 Home > Active Ingredient News > Study of Nervous System > JNNP: The effect of natalizumab on work performance in patients with multiple sclerosis

JNNP: The effect of natalizumab on work performance in patients with multiple sclerosis

 Last Update: 2022-09-07
 Source: Internet
 Author: User

Tags

fat life

omega 3 used

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Natalizumab has been shown to be highly effective in slowing disability progression and reducing disease activity in multiple sclerosis (MS) in randomized controlled trials (RCTs) 1 2 and data studies, but few studies have evaluated natalizumab Anti-influence on patient-reported outcomes, especially compared to other disease treatments (DMT)

The effect of DMT on treatment outcomes was previously studied in a population using DMT between 2010 and 2015

AMSLS is a survey-based cohort study established in 2002

Differences in the effect of severity between treatment groups

People using DMT were included in the analysis (n=1309 in 2015, n=1189 in 2016, and n=1229 in 2017)

In this large prospective cohort study, natalizumab was associated with higher outcomes over time in many patient-reported health and employment outcomes compared with other DMTs

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Pregabalin (CNS)

CAS No.: 148553-50-8

Pharmacy Grade

$1/KG FOB

Primidone CAS125-33-7

CAS No.: 125-33-7

Pharmaceutical Grade

$100/KG EXW

API Clomipramine HCl

CAS No.: 17321-77-6

Pharmacy Grade

$40-50/G FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.